-0.14 | -3.43%
| Price and Volume | |
|---|---|
| Recent Price | 3.94 |
| 52 Week High | 4.54 |
| 52 Week Low | 0.77 |
| Avg. Daily Vol. (Mil) | 0.22 |
| Beta (3 year) | 2.47 |
| Share Related Items | |
| Mkt Cap (Mil) | 116.74 |
| Shares Out (Mil) | 29.63 |
| Float (Mil) | 20.35 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.60 |
| Current Ratio | 1.60 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | 18.80 |
| Price/Sales | 3.53 |
| Price/Book | 4.69 |
| Price/Cash Flow | 15.80 |
| Per Share Data | |
| Earnings | 0.21 |
| Sales | 1.12 |
| Book Value | 0.84 |
| Cash Flow | 0.25 |
| Business Summary | |
|---|---|
| BioDelivery Sciences International, Inc. is a specialty pharmaceutical company that is leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties. | |
| General Information | |
| 801 Corporate Center Drive
Suite 210 Raleigh, NC 27607 |
|
| www.bdsi.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 17 | |
| CEO: Dr. Mark A. Sirgo,Pharm. | |
| Short Interest | |
| Current Month (Mil) | 1.05 |
| Previous Month (Mil) | 0.84 |
| Short Interest Ratio (Days) | 3.50 |
| Management Effectiveness | |
| Return on Equity | 24.10 |
| Return on Assets | 12.90 |
| Return on Investments | 24.10 |
| Profitability | |
| Gross Margin | 96.10 |
| EBIT Margin | 18.10 |
| Profit Margin | 18.10 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
107.26
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet